drugset / Trial / NCT01476696
A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the correct prasugrel dosage to be given to children with sickle cell disease (SCD).
Timeline
- Start
- 2011-11
- Primary completion
- 2012-11
- Completion
- 2012-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Prasugrel | Small molecule | 0.03 mg/kg | Oral |
| Subject | Prasugrel | Small molecule | 0.6 mg/kg | Oral |